Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients.

Keywords

Medicine, Myeloid leukemia, Leukemia, Transplantation, Immunology

References

• Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients.H-J Kolb, J. Mittermüller, Ch. Clemm — 1990
• Delayed infusion of normal donor cells after MHC-matched bone marrow transplantation provides an antileukemia reaction without graft-versus-host disease.B D Johnson, William R. Drobyski, R L Truitt — 1993
• Use of alpha interferon for the treatment of relapse of chronic myelogenous leukemia in chronic phase after allogeneic bone marrow transplantation.CS Higano, WH Raskind, Jack W. Singer — 1992
• Graft-versus-leukemia reactions after bone marrow transplantation.MM Horowitz, Gale Rp, Sondel Pm — 1990
• Competitive polymerase chain reaction to estimate the number of BCR-ABL transcripts in chronic myeloid leukemia patients after bone marrow transplantation.Nicholas C.P. Cross, L Feng, Andrew Chase — 1993
• Infusion of donor lymphocytes into stable canine radiation chimeras: implications for mechanism of transplantation tolerance.PL Weiden, Rainer Storb, Tsoi Ms — 1976
• Tumor necrosis factor mediates autocrine growth inhibition in a chronic leukemia.A. S. Duncombe, H E Heslop, Martin Turner — 1989
• Increased serum levels of tumor necrosis factor alpha precede major complications of bone marrow transplantation.Ernst Holler, HJ Kolb, A Möller — 1990
• Adoptive immunotherapy of acute leukemia: experimental and clinical results.G Mathé, Jeanne Amiel, L Schwarzenberg — 1965
• Graft-versus-host disease as adoptive immunotherapy in patients with advanced hematologic neoplasms.Keith M. Sullivan, Rainer Storb, C. Dean Buckner — 1989
• T-cell immunity to the joining region of p210BCR-ABL protein.W Chen, David Peace, Douglas Rovira — 1992
• Interferon-alpha and donor buffy coat transfusions for treatment of relapsed chronic myeloid leukemia after allogeneic bone marrow transplantation.Bernd Hertenstein, Markus Wiesneth, J. Novotný — 1993
• Cellularly defined minor histocompatibility antigens are differentially expressed on human hematopoietic progenitor cellsP.J. Voogt, E Goulmy, W. F. J. Veenhof — 1988
• Treatment of Murine Leukaemia with X Rays and Homologous Bone MarrowDavid W. Barnes, J. F. Loutit — 1956
• CLINICAL MANIFESTATIONS OF GRAFT‐VERSUS-HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL‐A-MATCHED SIBLING DONOR,SHarold Glucksberg, Rainer Storb, A Fefer — 1974
• Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation.Paul L. Weiden, Keith M. Sullivan, Nancy Flournoy — 1981
• Recognition of minor histocompatibility antigens on lymphocytic and myeloid leukemic cells by cytotoxic T-cell clones.D van der Harst, E Goulmy, JH Falkenburg — 1994
• Bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: importance of a graft‐versus‐leukaemia effectJane F. Apperley, Francesca Romana Mauro, John M. Goldman — 1988
• Donor leukocyte infusions for chronic myeloid leukemia relapsed after allogeneic bone marrow transplantation.Brigitte Bär, A Schattenberg, E. J. B. M. Mensink — 1993
• Induction of graft-versus-host disease as immunotherapy for relapsed chronic myeloid leukemia.David Porter, Mark S. Roth, C McGarigle — 1994

Cited by

• Adoptive immunotherapy in canine mixed chimeras after nonmyeloablative hematopoietic cell transplantation.George E. Georges, Rainer Storb, Jennifer D. Thompson — 2000
• Activated Long-Term Peripheral Blood Cultures as Preparation for Adoptive Alloreactive Cell Therapy in Cancer PatientsHerbert Edelsbrunner — 1997
• Human minor histocompatibility antigens: new concepts for marrow transplantation and adoptive immunotherapyDan Miodownik — 1997
• The rate and kinetics of molecular response to donor leucocyte transfusions in chronic myeloid leukaemia patients treated for relapse after allogeneic bone marrow transplantationKatrin R. Wilson — 1997
• Adoptive immunotherapy following allogeneic bone marrow transplantation.Rafael Gómez Fochs — 1998
• Induction of hyperacute graft-vs-host disease after donor leukocyte infusions.Jesús Fernández‐Herrera, Ruud Valks, Carlos Féal — 1999
• Mismatched transplants for refractory lymphoma?善道 坪井, 宏昭 続橋 — 1999
• Translocation (5;9)(q22;q34) in a case of acute lymphoblastic leukemia with multiple bone involvement: effectiveness of donor lymphocyte infusion for relapse after allogeneic stem cell transplantation.Hideki Tsujimura, Kyoya Kumagai, Akira Yokota — 2000
• High rate of secondary viral and bacterial infections in patients undergoing allogeneic bone marrow mini-transplantationВасильева Галина Михайловна — 2000
• Effect of induced GVHD in leukemia patients relapsing after allogeneic bone marrow transplantation: single-center experience of 33 adult patientsRúbia Guimarães Ribeiro — 2001
• Chemotherapy and granulocyte colony stimulating factor‐mobilized blood cell infusion followed by interferon‐α for relapsed malignancy after allogeneic bone marrow transplantationNicos Trimikliniotis — 2001
• Fatal graft-versus-host disease following HLA-mismatched donor lymphocyte infusionJudith Miller — 2001
• Decreased transfusion requirements for patients receiving nonmyeloablative compared with conventional peripheral blood stem cell transplants from HLA-identical siblings.Keiichi Yamada, Morimichi Mizuno, Toshihiko Tsukada — 2001
• Nonmyeloablative Allogeneic Hematopoietic Stem Cell TransplantationDavid Jou i Mirabent — 2002
• Development of a sample bank and clinical database for the retrospective analysis of unrelated bone marrow transplants : a pilot study of 138 transplants using RSCA for high resolution HLA matchingA. Pay — 2005
• Generation of minor histocompatibility antigen HA-1-specific cytotoxic T cells restricted by nonself HLA molecules: a potential strategy to treat relapsed leukemia after HLA-mismatched stem cell transplantation.Yu.K. Akimov, K.S. Marish, O.V. Savchenko — 2002
• Allogeneic hematopoietic stem cell transplantation in ovarian carcinoma: results of five patientsМарина Юрьевна Половникова — 2002
• Randomized trial of CD8+ T-cell depletion in the prevention of graft-versus-host disease associated with donor lymphocyte infusion.富男 仙田, 一男 平山, 紀一 大岡 — 2002
• Imatinib mesylate (STI571) in preparation for allogeneic hematopoietic stem cell transplantation and donor lymphocyte infusions in patients with Philadelphia-positive acute leukemiasJordi Nadal i Lorenzo, Xavier Esteve, Josep María Fullola i Pericot — 2003
• ‘GVHD’: graft-versus-host disease or graft-versus-Hodgkin's disease? an old acronym with new meaningDavid Porter, Edward A. Stadtmauer, H M Lazarus — 2003

Related papers

• Acute abdominal conditions in patients with leukemia.John A. Hawkins, William R. Mower, Edward William Nelson — 1985
• To learn about acute leukemiaN. M. Lyubimov — 1909
• [Clinical significance and expression of vascular endothelial growth factor in serum of patients with acute leukemia].Jian-min Xie, Zhenhua Qi — 2003
• Screening of serum biomarkers in acute leukemia by protein chipZhang Jun, Jianzhong Zhang, Hui-Fang Wang — 2007
• The application in screening of leukemia by complete blood cell count of electric impedanceZhang Ruizhen — 2009
• Analysis on syndrome types and prescriptions of leukemia in Chinese medicineWang Zhen-xu — 2013
• Graft-versus-leukemia in man: relationship of acute and chronic graft-versus-host disease to relapse of acute leukemia following allogeneic bone marrow transplantation.Sullivan Km, A Fefer, Robert P. Witherspoon — 1987
• Non-alloreactive T Cells Prevent Donor Lymphocyte Infusion-Induced Graft-vs.-Host Disease by Controlling Microbial StimuliHao Wei Li, Jessica Sachs, Clarimel Pichardo — 2012
• [The blood serum albumin transport function in patients with acute and chronic leukemias].Litvinov Av, Savchenko Vg, Tsepova El — 1998